FGF1 and breast adenocarcinoma: To test the anti-apoptotic activity of intracellular FGF1 in p53-positive cell lines other than U2OS, we used MCF7 (breast adenocarcinoma), BJ (normal fibroblasts) and HEK293 (embryonic human kidney) cells.